Eli Lilly (LLY) EBITDA (2009 - 2026)
Eli Lilly posted quarterly EBITDA of $9.5 billion for Q1 2026, up 80.35% year-on-year from $5.3 billion in Q1 2025, and up 6.69% on a QoQ basis from $8.9 billion in Q4 2025.
Eli Lilly (LLY) has 18 years of EBITDA data on file, last reported at $9.5 billion in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 80.35% year-over-year to $9.5 billion; the trailing twelve-month figure through Mar 2026 stood at $33.4 billion (up 77.64% YoY), and the FY2025 full-year result was $29.2 billion, up 80.56% from the prior year.
- EBITDA for Q1 2026 stood at $9.5 billion, up from $8.9 billion in the prior quarter.
- Across five years, EBITDA topped out at $9.5 billion in Q1 2026 and bottomed at $1.6 billion in Q1 2023.
- The 5-year median for EBITDA is $3.4 billion (2023), against an average of $4.3 billion.
- The widest annual swing landed in 2023, when EBITDA sank 37.78%; it then jumped 101.07% in 2025.
- A 5-year view of EBITDA shows it stood at $2.1 billion in 2022, then jumped by 44.94% to $3.0 billion in 2023, then surged by 77.35% to $5.3 billion in 2024, then jumped by 66.8% to $8.9 billion in 2025, then gained by 6.69% to $9.5 billion in 2026.
- The last three EBITDA figures came in at $9.5 billion (Q1 2026), $8.9 billion (Q4 2025), and $8.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 9.50 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.36 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.99 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.83 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.50 Bn |
| Dec 31, 2025 | 8.90 Bn |
| Sep 30, 2025 | 8.02 Bn |
| Jun 30, 2025 | 7.02 Bn |
| Mar 31, 2025 | 5.27 Bn |
| Dec 31, 2024 | 5.34 Bn |
| Sep 30, 2024 | 4.35 Bn |
| Jun 30, 2024 | 3.87 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 3.01 Bn |
| Sep 30, 2023 | 3.43 Bn |
| Jun 30, 2023 | 2.22 Bn |
| Mar 31, 2023 | 1.60 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 1.74 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 2.57 Bn |
| Dec 31, 2021 | 2.35 Bn |
| Sep 30, 2021 | 2.06 Bn |
| Jun 30, 2021 | 1.45 Bn |
| Mar 31, 2021 | 1.47 Bn |
| Dec 31, 2020 | 2.47 Bn |
| Sep 30, 2020 | 1.28 Bn |
| Jun 30, 2020 | 1.44 Bn |
| Mar 31, 2020 | 1.64 Bn |
| Dec 31, 2019 | 1.55 Bn |
| Sep 30, 2019 | 1.51 Bn |
| Jun 30, 2019 | 1.52 Bn |
| Mar 31, 2019 | 1.21 Bn |
| Dec 31, 2018 | 1.42 Bn |
| Sep 30, 2018 | 1.42 Bn |
| Jun 30, 2018 | 1.59 Bn |
| Mar 31, 2018 | 1.35 Bn |
| Dec 31, 2017 | 1.23 Bn |
| Sep 30, 2017 | 1.15 Bn |
| Jun 30, 2017 | 1.25 Bn |
| Mar 31, 2017 | 1.05 Bn |
| Dec 31, 2016 | 1.05 Bn |
| Sep 30, 2016 | 989.00 Mn |
| Jun 30, 2016 | 981.30 Mn |
| Mar 31, 2016 | 847.20 Mn |
| Dec 31, 2015 | 743.80 Mn |
| Sep 30, 2015 | 1.00 Bn |
| Jun 30, 2015 | 955.40 Mn |
| Mar 31, 2015 | 889.20 Mn |
| Dec 31, 2014 | 882.60 Mn |
| Sep 30, 2014 | 693.30 Mn |
| Jun 30, 2014 | 886.60 Mn |
| Mar 31, 2014 | 866.20 Mn |
| Dec 31, 2013 | 993.30 Mn |
| Sep 30, 2013 | 1.54 Bn |
| Jun 30, 2013 | 1.57 Bn |
| Mar 31, 2013 | 1.44 Bn |
| Dec 31, 2012 | 1.27 Bn |
| Sep 30, 2012 | 1.14 Bn |
| Jun 30, 2012 | 1.20 Bn |
| Mar 31, 2012 | 1.41 Bn |
| Dec 31, 2011 | 1.07 Bn |
| Sep 30, 2011 | 1.59 Bn |
| Jun 30, 2011 | 1.59 Bn |
| Mar 31, 2011 | 1.67 Bn |
| Dec 31, 2010 | 1.45 Bn |
| Sep 30, 2010 | 1.53 Bn |
| Jun 30, 2010 | 1.60 Bn |
| Mar 31, 2010 | 1.68 Bn |
| Dec 31, 2009 | 1.30 Bn |
| Sep 30, 2009 | 959.90 Mn |
| Jun 30, 2009 | 1.49 Bn |
| Mar 31, 2009 | 1.75 Bn |